drug

aflibercept-abzv

1 story · latest Oct 22, 2026

Follow aflibercept-abzv. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Aug 2024 · BLA761382
Brand: Enzeevu

Relationships

Developed by Sandoz

Timeline

FDA clears second submission under Sandoz's Enzeevu biologics license application

Oct 22Regulatory decisionaflibercept-abzv Sandoz

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.